Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03602391 · ClinicalTrials.gov registry record · NA

The Senior Companion Program Plus

A NA study of Family and Alzheimer Dementia, sponsored by The University of Texas at Arlington.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT03602391: Completed NA study of Family and Alzheimer Dementia, sponsored by The University of Texas at Arlington.

NCT03602391 is a NA study of Family and Alzheimer Dementia that has completed, run by The University of Texas at Arlington. The registered enrollment target is 20 participants, below the 188-participant average among 9 other Family trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03602391, a NA study of Family and Alzheimer Dementia, has completed, sponsored by The University of Texas at Arlington.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

Alzheimer's disease and related dementia (ADRD) is one of the most challenging chronic health conditions in the United States and considerable disparities exist in the diagnosis and prevalence of ADRD among communities of color. Research suggests that ADRD caregiver interventions have demonstrated efficacy, however, it remains unknown whether existing ADRD caregiver interventions are useful or accessible to African American ADRD caregivers in community settings. The primary goal of the proposed project is to develop an in-home psychoeducational intervention (The Senior Companion Program Plus, or SCP Plus) that is accessible, sustainable, and affordable for African American ADRD caregivers. The SCP Plus will focus on African American ADRD caregivers who are particularly affected by poverty, discrimination, and barriers to health care services and supports. A recent pilot study has established the feasibility and utility of SCP Plus. With the assistance of 6 student research assistants over the course of the project, we will implement the SCP Plus at sites in Texas, Louisiana, and Arkansas, recruiting approximately 114 participants. The participants will be randomized with 57 caregivers receiving the SCP Plus and 57 caregivers receiving services as usual with the Senior Companion Program. A weekly, 60 minute psychoeducational module will be delivered face-to-face across 9 weeks and will focus on education about ADRD, behavior management, communication skills, and aspects of providing care that enhance meaning such as spirituality. In order to provide an accessible and cost effective intervention that is potentially sustainable, senior companions will be trained to provide the intervention in the homes of the African American ADRD caregivers. Specific Aim 1. Determine whether SCP Plus reduces level of burden and stress among African American caregivers over a 3- and 6-month period when compared to a usual care control group. Specific Aim 2. Ascertain if SCP Plus imp

Primary Outcome

The 22-item version of the Zarit Burden Interview (ZBI) will be used to test caregiver stress and/or burden. The ZBI was developed to measure burden among caregivers of community-dwelling persons with dementia. The items are scored from 0 (never); 1 (rarely); 2 (sometimes); 3 (quite frequently); 4 (nearly always) with higher scores indicating higher levels of distress. Total scores can range from 0 to 88. Median of the 22 items is analyzed. Overall median of participants is reported. All survey

Interventions

  • BEHAVIORAL SCP Plus

Study Locations (1)

Texas

  • The Senior Source - Dallas

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2019-05-16
Est. Completion 2023-06-30
Phase NA

What the finished NCT03602391 record still lists

NCT03602391 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 188-participant average among 9 other Family trials with a reported enrollment target (89% lower).

The record links to 2 conditions, with Family appearing as the primary indexed condition, and to 1 intervention - of which SCP Plus is the first listed.

NCT03602391 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT03602391 about?

NCT03602391 is a clinical study titled "The Senior Companion Program Plus". Alzheimer's disease and related dementia (ADRD) is one of the most challenging chronic health conditions in the United States and considerable disparities exist in the diagnosis and prevalence of ADRD among communities of color. Research suggests that ADRD caregiver interventions have demonstrated e...

What is the current status of trial NCT03602391?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2019-05-16. Estimated completion is 2023-06-30.

What conditions does trial NCT03602391 study?

This clinical trial studies the following conditions: Family, Alzheimer Dementia.

What interventions are being tested in trial NCT03602391?

The interventions under investigation include: SCP Plus (BEHAVIORAL).

Who is sponsoring clinical trial NCT03602391?

This trial is sponsored by The University of Texas at Arlington, which has 32 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03602391 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Family

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03602391's enrollment target sits among peer trials

20 9th of 9 higher than 1 of 9 other Family trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Family trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03602391, the US trial registry maintained by the National Library of Medicine. NCT03602391 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.